CNO Financial Group, Inc. (CNO)
- Previous Close
28.81 - Open
28.92 - Bid 28.51 x 900
- Ask 29.30 x 800
- Day's Range
28.82 - 29.00 - 52 Week Range
21.52 - 29.00 - Volume
625,162 - Avg. Volume
748,322 - Market Cap (intraday)
3.129B - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
8.45 - EPS (TTM)
3.42 - Earnings Date Jul 29, 2024 - Aug 2, 2024
- Forward Dividend & Yield 0.64 (2.21%)
- Ex-Dividend Date Jun 10, 2024
- 1y Target Est
29.00
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, insurance products, and financial services for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.
www.cnoinc.com3,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CNO
Performance Overview: CNO
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CNO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CNO
Valuation Measures
Market Cap
3.13B
Enterprise Value
6.46B
Trailing P/E
8.45
Forward P/E
9.00
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.77
Price/Book (mrq)
1.32
Enterprise Value/Revenue
1.50
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
9.07%
Return on Assets (ttm)
1.36%
Return on Equity (ttm)
17.71%
Revenue (ttm)
4.3B
Net Income Avi to Common (ttm)
389.6M
Diluted EPS (ttm)
3.42
Balance Sheet and Cash Flow
Total Cash (mrq)
789.1M
Total Debt/Equity (mrq)
164.53%
Levered Free Cash Flow (ttm)
521.3M
Research Analysis: CNO
Company Insights: CNO
CNO does not have Company Insights